SCHEDULE: Morgan Stanley Discloses 8% Stake in Nuveen Impact Fund

Sentiment:

Beneficial Ownership Report


Morgan Stanley and its subsidiary, Parametric Portfolio Associates LLC, have reported an 8.0% beneficial ownership stake in Nuveen Core Plus Impact Fund.

Summary

  • Morgan Stanley and its wholly-owned subsidiary, Parametric Portfolio Associates LLC, collectively hold 2,290,571 Common Shares of Beneficial Interest in Nuveen Core Plus Impact Fund.
  • This represents an 8.0% beneficial ownership stake in the issuer's class of securities.
  • The reporting persons have shared voting power over 215,942 shares and shared dispositive power over all 2,290,571 shares.
  • The filing is an Amendment No. 3 to Schedule 13G, indicating previous filings have been made.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as moderately positive, as a significant stake by a reputable institution like Morgan Stanley can be interpreted as a vote of confidence in the Nuveen Core Plus Impact Fund, potentially attracting further investor interest.

Positives

  • A significant 8.0% stake by a major financial institution like Morgan Stanley and its investment advisory subsidiary, Parametric Portfolio Associates LLC, signals institutional confidence in Nuveen Core Plus Impact Fund.
  • The acquisition of shares in the ordinary course of business suggests a strategic investment rather than an activist position.

Negatives

  • NA

Risks

  • NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that the disclosure of an 8.0% stake by Morgan Stanley, through its subsidiary Parametric Portfolio Associates LLC, in Nuveen Core Plus Impact Fund highlights continued institutional interest in impact investing and closed-end funds. This type of significant passive investment by a major financial services firm often reflects a belief in the long-term value and stability of the underlying fund's strategy, particularly within the growing impact investment sector.

Related Party Transactions

  • Parametric Portfolio Associates LLC, which holds the beneficial ownership, is a wholly-owned subsidiary of Morgan Stanley, the parent holding company. This relationship is explicitly stated in Exhibit 99.2.

Stakeholder Impact

  • Shareholders: The disclosure of a significant institutional holder like Morgan Stanley could enhance investor confidence and potentially improve liquidity for Nuveen Core Plus Impact Fund shares.
  • Management: The presence of a large, passive institutional investor may encourage management to maintain strong governance and performance.

Key Dates

DateDescription
12/31/2025Date of event which requires filing of this statement (reporting period end date).
02/12/2026Signature date for Morgan Stanley and Parametric Portfolio Associates LLC.

Recommendation

hold

The filing indicates a significant, passive institutional investment by Morgan Stanley in Nuveen Core Plus Impact Fund. While this is a positive signal of confidence, the filing itself does not provide new operational or financial data about the fund to warrant a 'buy' or 'sell' recommendation. It primarily confirms a substantial ownership position, suggesting a 'hold' for existing investors and further due diligence for potential new investors to understand the fund's underlying performance and strategy.

Keywords

Nuveen Core Plus Impact Fund, Morgan Stanley, Parametric Portfolio Associates LLC, Schedule 13G, Beneficial Ownership, Institutional Investment, Impact Fund, Common Shares, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.